Literature DB >> 26862506

Current views of the relationship between Helicobacter pylori and Henoch-Schonlein purpura in children.

Li-Jing Xiong1, Meng Mao1.   

Abstract

Helicobacter pylori (H. pylori) is one of the factors involved in the pathogenesis of various gastrointestinal diseases and may play a potential role in certain extra-intestinal diseases. H. pylori infection are mainly acquired during childhood, and it has been reported that in endemic areas of China the infection rates are extraordinarily higher in HSP children, particular those with abdominal manifestations. Furthermore, eradication therapy may ameliorate Henoch-Schonlein purpura (HSP) manifestations and decrease the recurrence of HSP. Therefore, results suggested that detection of H. pylori infection by appropriate method ought to be applied in HSP children. Current evidences indicate that local injury of gastric mucosa and immunological events induced by H. pylori infection are involved in the development of HSP. Increased serum IgA, cryoglobulins, C3 levels, autoimmunity, proinflammatory substances and molecular mimicry inducing immune complex and cross-reactive antibodies caused by H. pylori infection might play their roles in the course of HSP. However, there are no investigations confirming the causality between H. pylori infection and HSP, and the pathogenesis mechanism is still unclear. More bench and clinical studies need to be executed to elaborate the complex association between H. pylori and HSP.

Entities:  

Keywords:  Children; Helicobacter pylori; Henoch-Schonlein purpura

Year:  2016        PMID: 26862506      PMCID: PMC4737697          DOI: 10.5409/wjcp.v5.i1.82

Source DB:  PubMed          Journal:  World J Clin Pediatr        ISSN: 2219-2808


  70 in total

1.  DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection.

Authors:  Mathias Oertli; Malin Sundquist; Iris Hitzler; Daniela B Engler; Isabelle C Arnold; Sebastian Reuter; Joachim Maxeiner; Malin Hansson; Christian Taube; Marianne Quiding-Järbrink; Anne Müller
Journal:  J Clin Invest       Date:  2012-02-06       Impact factor: 14.808

2.  Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.

Authors:  P Malfertheiner; F Megraud; C O'Morain; F Bazzoli; E El-Omar; D Graham; R Hunt; T Rokkas; N Vakil; E J Kuipers
Journal:  Gut       Date:  2006-12-14       Impact factor: 23.059

3.  Iron deficiency and Helicobacter pylori infection in the United States.

Authors:  Victor M Cardenas; Zuber D Mulla; Melchor Ortiz; David Y Graham
Journal:  Am J Epidemiol       Date:  2005-11-23       Impact factor: 4.897

4.  Effect of eradication of Helicobacter pylori and iron supplementation on the iron status of children with iron deficiency.

Authors:  Ximena Duque; Segundo Moran; Robertino Mera; Mayela Medina; Homero Martinez; Maria E Mendoza; Javier Torres; Pelayo Correa
Journal:  Arch Med Res       Date:  2010-03-15       Impact factor: 2.235

5.  Schönlein-Henoch vasculitis and chronic Helicobacter pylori associated gastritis and duodenal ulcer: a case report.

Authors:  R Mozrzymas; E S d'Amore; G Montini; G Guariso
Journal:  Pediatr Med Chir       Date:  1997 Nov-Dec

6.  Geographic distribution of vacA allelic types of Helicobacter pylori.

Authors:  L J Van Doorn; C Figueiredo; F Mégraud; S Pena; P Midolo; D M Queiroz; F Carneiro; B Vanderborght; M D Pegado; R Sanna; W De Boer; P M Schneeberger; P Correa; E K Ng; J Atherton; M J Blaser; W G Quint
Journal:  Gastroenterology       Date:  1999-04       Impact factor: 22.682

7.  Investigation of the change in CD4⁺ T cell subset in children with Henoch-Schonlein purpura.

Authors:  Yuan-Yuan Li; Cheng-Rong Li; Guo-Bing Wang; Jun Yang; Ying Zu
Journal:  Rheumatol Int       Date:  2011-12-21       Impact factor: 2.631

8.  The combination of Helicobacter pylori- and cytotoxin-associated gene-A seropositivity in relation to the risk of myocardial infarction in middle-aged Japanese: The Japan Public Health Center-based study.

Authors:  Ai Ikeda; Hiroyasu Iso; Shizuka Sasazuki; Manami Inoue; Shoichiro Tsugane
Journal:  Atherosclerosis       Date:  2013-07-04       Impact factor: 5.162

9.  [Relationship between Helicobacter pylori infection and Henoch-Schonlein purpura with gastrointestinal involvement in children].

Authors:  Bing-Hui Wang; Li-Qun Zhou; Ya-Hua Zuo
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2007-08

10.  IL-23 Contributes to Control of Chronic Helicobacter Pylori Infection and the Development of T Helper Responses in a Mouse Model.

Authors:  Dennis J Horvath; M Kay Washington; Vicki A Cope; Holly M Scott Algood
Journal:  Front Immunol       Date:  2012-03-26       Impact factor: 7.561

View more
  6 in total

Review 1.  Helicobacter pylori Infection in Pediatric Patients: Update on Diagnosis and Eradication Strategies.

Authors:  Kallirroi Kotilea; Nicolas Kalach; Matjaž Homan; Patrick Bontems
Journal:  Paediatr Drugs       Date:  2018-08       Impact factor: 3.022

Review 2.  A Case of Henoch-Schonlein Purpura Associated with Rotavirus Infection in an Elderly Asian Male and Review of the Literature.

Authors:  Chen Tang; Daphne Scaramangas-Plumley; Cynthia C Nast; Zab Mosenifar; Marc A Edelstein; Michael Weisman
Journal:  Am J Case Rep       Date:  2017-02-08

3.  Efficacy of montelukast for the treatment of pediatric allergic purpura.

Authors:  Li-Ping Bai; Jing Yu; Ya-Xin Sun; Jiu-Mei Wang
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

Review 4.  IgA vasculitis update: Epidemiology, pathogenesis, and biomarkers.

Authors:  Liyun Xu; Yongzhen Li; Xiaochuan Wu
Journal:  Front Immunol       Date:  2022-10-03       Impact factor: 8.786

5.  Streptococcal infection in childhood Henoch-Schönlein purpura: a 5-year retrospective study from a single tertiary medical center in China, 2015-2019.

Authors:  Guo Zhen Fan; Rui Xue Li; Qi Jiang; Man Man Niu; Zhen Qiu; Wei Xia Chen; Hui Hui Liu; Jin Wei Ruan; Peng Hu
Journal:  Pediatr Rheumatol Online J       Date:  2021-06-02       Impact factor: 3.054

6.  Differences in Manifestations and Gut Microbiota Composition Between Patients With Different Henoch-Schonlein Purpura Phenotypes.

Authors:  Yuanzhen Zhang; Guizhi Xia; Xiaojing Nie; Yugui Zeng; Yi Chen; Yifang Qian; Guangming Chen; Jun Huang; Chengfeng Wang; Chuanyin Zhang; Xiaoli Huang; Yuen Yang; Xiaojian Qiu; Fang Yang; Jie Chen; Jun Hu
Journal:  Front Cell Infect Microbiol       Date:  2021-07-01       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.